Accès gratuit
Numéro
Réanimation
Volume 25, Numéro 3, Mai 2016
Infectieux
Page(s) 296 - 307
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-016-1176-5
Publié en ligne 14 mars 2016
  • Leroy O, Meybeck A, Sarraz-Bournet B, et al (2012) Vascular graft infections. Curr Opin Infect Dis 25:154–8 [CrossRef] [PubMed] [Google Scholar]
  • Fitzgerald SF, Kelly C, Humphreys H (2005) Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 56:996–9 [CrossRef] [PubMed] [Google Scholar]
  • Haute Autorité de santé. Évaluation des implants de pontage. http://www.has-sante.fr/portail/jcms/c_1528392/fr/rapport-d-evaluation-des-implants-de-pontage [Google Scholar]
  • Haute Autorité de santé. Implant endovasculaire dit stent aortique, rénal, iliaque ou fémoral - Note de cadrage. http://www.has-sante.fr/portail/jcms/c_1777246/fr/implant-endovasculaire-dit-stent-aortique-renal-iliaque-ou-femoral-note-de-cadrage [Google Scholar]
  • Kitamura T, Morota T, Motomura N, et al (2005) Management of infected grafts and aneurysms of the aorta. Ann Vasc Surg 19:335–42 [CrossRef] [PubMed] [Google Scholar]
  • Kieffer E, Sabatier J, Plissonnier D, et al (2001) Prosthetic graft infection after descending thoracic/thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vasc Surg 33:671–8 [CrossRef] [PubMed] [Google Scholar]
  • Batt M, Jean-Baptiste E, O'Connor S, et al (2008) In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg 36:182–8 [CrossRef] [PubMed] [Google Scholar]
  • Bandyk DF, Novotney ML, Back MR, et al (2001) Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 34:411–9 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, D'Elia P, Devos P, et al (2012) Risk factors for methicillin-resistant staphylococcal vascular graft infection in an 11-year cohort study. J Infect 64:441–42 [CrossRef] [PubMed] [Google Scholar]
  • Vogt PR, Brunner-La Rocca HP, Carrel T, et al (1998) Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg 116:965–72 [CrossRef] [PubMed] [Google Scholar]
  • Fiorani P, Speziale F, Rizzo L, et al (1997) Long-term follow-up after in situ graft replacement in patients with aortofemoral graft infections. Eur J Vasc Endovasc Surg 14:111–49 [CrossRef] [PubMed] [Google Scholar]
  • Roy D, Grove DI (2000) Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. J Infect 40:184–7 [CrossRef] [PubMed] [Google Scholar]
  • Postier RG, Green SL, Klein SR, et al (2004) Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients. Clin Ther 26:704–14 [CrossRef] [PubMed] [Google Scholar]
  • Vogt PR, Brunner-LaRocca HP, Lachat M, et al (2002) Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg 35:80–6 [CrossRef] [PubMed] [Google Scholar]
  • Revest M, Camou F, Senneville E, et al (2015) Medical treatment of prosthetic vascular graft infections: review of the literature and proposals of a working group. Int J Antimicrob Agents 46:254–65 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, Sarraz-Bournet B, D'Elia PV, et al (2012) Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect 18:352–8 [CrossRef] [PubMed] [Google Scholar]
  • Habib G, Lancellotti P, Antunes MJ, et al (2015) 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 36:3075–128 [CrossRef] [PubMed] [Google Scholar]
  • InVS. Résistance aux anti-infectieux, données par pathogène. [10/30/2015] (2015); http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Resistance-aux-anti-infectieux/Donnees-par-pathogene [Google Scholar]
  • Cremniter J, Slassi A, Quincampoix JC, et al (2010) Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol 48:1428–31 [CrossRef] [PubMed] [Google Scholar]
  • Liakopoulos A, Neocleous C, Klapsa D, et al (2009) A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis. J Antimicrob Chemother 64:206–7 [CrossRef] [PubMed] [Google Scholar]
  • Lodise TP, Patel N, Lomaestro BM, et al (2009) Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 49:507–14 [CrossRef] [PubMed] [Google Scholar]
  • Patel N, Pai MP, Rodvold KA, Lomaestro B, et al (2011) Vancomycin: we can't get there from here. Clin Infect Dis 52:969–74 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, D'Elia P, Sarraz-Bournet B, et al (2014) Tolerability of high doses of daptomycin in the treatment of prosthetic vascular graft infection: a retrospective study. Infect Dis Ther 3:215–23 [CrossRef] [PubMed] [Google Scholar]
  • Miro JM, Entenza JM, Del Rio A, et al (2012) High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 56:4511–5 [CrossRef] [PubMed] [Google Scholar]
  • ANSM : notice fosfomycine. http://agence-rd.ansm.sante.fr/php/ecodex/frames.php?specid=63322018&typedoc=N&ref=N0188958.htm [Google Scholar]
  • Legout L, D’Elia P, Sarraz-Bournet B, et al (2014) Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin. BMC Infect Dis 14:228 [CrossRef] [PubMed] [Google Scholar]
  • ONERBA. Annual Report 2011–2012 (2014): http://www.onerba.org/IMG/pdf/onerba_rapport_2011_web.pdf [Google Scholar]
  • Nordmann P, Naas T, Poirel L (2011). Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–8 [CrossRef] [PubMed] [Google Scholar]
  • Szczot M, Meybeck A, Legout L, et al (2011) Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect 62:204–11 [CrossRef] [PubMed] [Google Scholar]
  • Nagy E, Urban E, Nord CE, Bacteria ESGoARiA (2011) Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect 17:371–9 [CrossRef] [PubMed] [Google Scholar]
  • Leon C, Ruiz-Santana S, Saavedra P, et al (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–33 [CrossRef] [PubMed] [Google Scholar]
  • Pappas PG, Kauffman CA, Andes DR, et al (2015) Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis doi: 10.1093/cid/civ933 [Google Scholar]
  • Hoiby N, Bjarnsholt T, Moser C, et al (2015) ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 21:S1–S25 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, D'Elia PV, Sarraz-Bournet B, et al (2012) Diagnosis and management of prosthetic vascular graft infections. Med Mal Infect 42 :102–9 [CrossRef] [PubMed] [Google Scholar]
  • Paul M, Zemer-Wassercug N, Talker O, et al (2011) Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 17:1581–6 [CrossRef] [PubMed] [Google Scholar]
  • Bai AD, Showler A, Burry L, et al (2015) Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother 70:1539–46 [CrossRef] [PubMed] [Google Scholar]
  • González C, Rubio M, Romero-Vivas J, et al (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29:1171–7 [CrossRef] [PubMed] [Google Scholar]
  • Forrest GN, Tamura K (2010) Rifampin combination therapy for non-mycobacterial infections. Clin Microbiol Rev 23:14–34 [CrossRef] [PubMed] [Google Scholar]
  • Van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755–71 [CrossRef] [PubMed] [Google Scholar]
  • Jacob JT, Diaz Granados CA (2013) High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17: e93–e100 [CrossRef] [PubMed] [Google Scholar]
  • Liu C, Bayer A, Cosgrove SE, et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–92 [CrossRef] [PubMed] [Google Scholar]
  • La Plante KL, Woodmansee S (2009) Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother 53:3880–6 [CrossRef] [PubMed] [Google Scholar]
  • Raad I, Hanna H, Jiang Y, et al (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51:1656–60 [CrossRef] [PubMed] [Google Scholar]
  • Perrottet N, Steinrücken J, Chan M, et al (2015) Efficacy and safety of high-dose daptomycin (> 6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram positive bacteria. Int J Antimicrob Agents 46:480–2 [CrossRef] [PubMed] [Google Scholar]
  • Miró JM, Entenza JM, Del Río A, et al (2012) High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 56:4511–5 [CrossRef] [PubMed] [Google Scholar]
  • Moore CL, Osaki-Kiyan P, Haque NZ, et al (2012) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 54:51–8 [CrossRef] [PubMed] [Google Scholar]
  • Corvec S, Furustrand Tafin U, Betrisey B, et al (2013) Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-beta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 57:1421–7 [CrossRef] [PubMed] [Google Scholar]
  • Vasoo S, Cunningham SA, Cole NC, et al (2015) In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing Gram negative bacilli. Antimicrob Agents Chemother 59:7842–6 [CrossRef] [PubMed] [Google Scholar]
  • Maiolo EM, Furustrand Tafin U, Borens O, Trampuz A (2014) Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrob Agents Chemother 58:2709–17 [CrossRef] [PubMed] [Google Scholar]
  • SPILF (2009) Recommandations de pratique clinique. Infections ostéoarticulaires sur matériel (prothèse, implant, ostéosynthèse). http://www.infectiologie.com/fr/recommandations.htm [Google Scholar]
  • Segreti J, Nelson JA, Trenholme GM (1998) Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 27:711–3 [CrossRef] [PubMed] [Google Scholar]
  • Aukema TS, Legemate DA (2009) Gluteopopliteal bypass for a compromised groin. J Vasc Surg 49:483–5 [CrossRef] [PubMed] [Google Scholar]
  • Mertens RA, O'Hara PJ, Hertzer NR, et al (1995) Surgical management of infrainguinal arterial prosthetic graft infections: review of a thirty-five-year experience. J Vasc Surg 21:782–90 [CrossRef] [PubMed] [Google Scholar]
  • Murphy EH, Szeto WY, Herdrich BJ, et al (2013) The management of endograft infections following endovascular thoracic and abdominal aneurysm repair. J Vasc Surg 58:1179–85 [CrossRef] [PubMed] [Google Scholar]
  • Oderich GS, Bower TC, Cherry KJ, et al (2006) Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg 43:1166–74 [CrossRef] [PubMed] [Google Scholar]
  • Jean-Baptiste E, Blanchemain N, Neut C, et al (2014) Evaluation of the anti-infectious properties of polyester vascular prostheses functionalised with cyclodextrin. J Infect 68:116–24 [CrossRef] [PubMed] [Google Scholar]
  • Topel I, Audebert F, Betz T, Steinbauer MG (2010) Microbial spectrum and primary resistance to rifampicin in infectious complications in vascular surgery: limits to the use of rifampicin-bonded prosthetic grafts. Angiology 61:423–6 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.